99mTechnetium pyrophosphate scintigraphy in the detection of skeletal muscle disease

Clinical Rheumatology

Volumn 26, Issue 7, 2007, Pages 1119-1122

  Walker, Ulrich A ^a   Garve, K ^a   Brink, I ^a   Miehle, N ^a   Peter, H H ^a   Kelly, T ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

99mTechnetium pyrophosphate; Myopathy; Myositis; Radionuclide imaging; Skeletal muscle

Indexed keywords

C REACTIVE PROTEIN; CORTICOSTEROID; CREATINE KINASE; IMMUNOSUPPRESSIVE AGENT; PREDNISONE; PYROPHOSPHATE TECHNETIUM TC 99M; BIOLOGICAL MARKER; DIAGNOSTIC AGENT;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CREATINE KINASE BLOOD LEVEL; DERMATOMYOSITIS; DIAGNOSTIC ACCURACY; FALSE POSITIVE RESULT; FEMALE; HUMAN; HUMAN TISSUE; INCLUSION BODY MYOSITIS; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MUSCLE BIOPSY; MUSCLE WEAKNESS; MYALGIA; MYOPATHY; PATIENT SELECTION; POLYMYOSITIS; PRIORITY JOURNAL; SCINTISCANNING; SENSITIVITY AND SPECIFICITY; STATISTICAL MODEL; ADOLESCENT; BLOOD; METABOLISM; MIDDLE AGED; MUSCLE DISEASE; PAIN; PATHOLOGY; SKELETAL MUSCLE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CREATINE KINASE; FEMALE; HUMANS; MALE; MIDDLE AGED; MUSCLE WEAKNESS; MUSCLE, SKELETAL; MUSCULAR DISEASES; PAIN; POLYMYOSITIS; SENSITIVITY AND SPECIFICITY; TECHNETIUM TC 99M PYROPHOSPHATE;

EID: 34249892154     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10067-006-0463-3     Document Type: Article

References (14)

1. Tanimoto K, Nakano K, Kano S et al (1995) Classification criteria for polymyositis and dermatomyositis. J Rheumatol 22:668-674
2. Spies SM, Swift TR, Brown M (1975) Increased 99m Tc-polyphosphate muscle uptake in a patient with polymyositis: Case report. J Nucl Med 16:1125-1127
3. 99m Tc-pyrophosphate bone scan in polymyositis. Radiology 122:168
4. Bellina CR, Bianchi R, Bombardieri S et al (1978) Quantitative evaluation of 99mTc-pyrophosphate muscle uptake in patients with inflammatory and noninflammatory muscle diseases. J Nucl Med Allied Sci 22:89-96
5. Messina C, Bonanno N, Baldari S, Vita G (1982) Muscle uptake of 99m technetium pyrophosphate in patients with neuromuscular disorder. A quantitative study. J Neurol Sci 53:1-7
6. von Kempis J, Kalden P, Gutfleisch J et al (1998) Diagnosis of idiopathic myositis: Value of 99m technetium pyrophosphate muscle scintigraphy and magnetic resonance imaging in targeted muscle biopsy. Rheumatol Int 17:207-213
7. Jaeschke R, Guyatt GH, Sackett DL (1994) Users' guides to the medical literature. III. How to use an article about a diagnostic test. B. What are the results and will they help me in caring for my patients? The Evidence-Based Medicine Working Group. JAMA 271:703-707
8. Altman DG, Bland JM (1994) Diagnostic tests. 1: Sensitivity and specificity. BMJ 308:1552
9. Kula RW, Line BR, Siegel BA, Jones AE, Johnston GS, Engel WK (1976) 99m Tc-diphosphonate scanning of soft tissue in neuromuscular diseases. Neurology 26:370 (Abstract)
10. Crenshaw AG, Friden J, Hargens AR, Lang GH, Thornell LE (1993) Increased technetium uptake is not equivalent to muscle necrosis: Scintigraphic, morphological and intramuscular pressure analyses of sore muscles after exercise. Acta Physiol Scand 148:187-198
11. Vita G, Harris JB (1981) The uptake of 99m technetium diphosphonate into degenerating and regenerating muscle. A correlative histological and biochemical study. J Neurol Sci 51:339-354
12. Yonker RA, Webster EM, Edwards NL et al (1987) Technetium pyrophosphate muscle scans in inflammatory muscle disease. Br J Rheumatol 26:267-269
13. 99mTc pyrophosphate scintigraphy. Rinsho Shinkeigaku 40:145-148
14. Walker RE, Eustace SJ (2001) Whole-body magnetic resonance imaging: techniques, clinical indications, and future applications. Semin Musculoskelet Radiol 5:5-20